PT1311486E - Uso de taliporfina ou dos seus derivados no tratamento de doencas cardiacas e preparacao da mesma - Google Patents

Uso de taliporfina ou dos seus derivados no tratamento de doencas cardiacas e preparacao da mesma

Info

Publication number
PT1311486E
PT1311486E PT01921112T PT01921112T PT1311486E PT 1311486 E PT1311486 E PT 1311486E PT 01921112 T PT01921112 T PT 01921112T PT 01921112 T PT01921112 T PT 01921112T PT 1311486 E PT1311486 E PT 1311486E
Authority
PT
Portugal
Prior art keywords
derivatives
treatment
taliporfin
preparation
same
Prior art date
Application number
PT01921112T
Other languages
English (en)
Inventor
Su Mingjai
Lee Shoeisheng
Original Assignee
Lotus Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/644,932 external-priority patent/US6313134B1/en
Application filed by Lotus Pharmaceutical Co Ltd filed Critical Lotus Pharmaceutical Co Ltd
Publication of PT1311486E publication Critical patent/PT1311486E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PT01921112T 2000-08-23 2001-02-28 Uso de taliporfina ou dos seus derivados no tratamento de doencas cardiacas e preparacao da mesma PT1311486E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/644,932 US6313134B1 (en) 2000-05-04 2000-08-23 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same

Publications (1)

Publication Number Publication Date
PT1311486E true PT1311486E (pt) 2006-09-29

Family

ID=24586946

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01921112T PT1311486E (pt) 2000-08-23 2001-02-28 Uso de taliporfina ou dos seus derivados no tratamento de doencas cardiacas e preparacao da mesma

Country Status (19)

Country Link
EP (1) EP1311486B1 (pt)
JP (1) JP2004506719A (pt)
KR (1) KR100522008B1 (pt)
CN (1) CN1176909C (pt)
AT (1) ATE325099T1 (pt)
AU (2) AU2001248226B2 (pt)
BR (1) BR0111761A (pt)
CA (1) CA2412170C (pt)
CY (1) CY1105432T1 (pt)
DE (1) DE60119336T2 (pt)
DK (1) DK1311486T3 (pt)
ES (1) ES2260209T3 (pt)
HU (1) HUP0301971A3 (pt)
IL (1) IL153205A (pt)
MX (1) MXPA02012316A (pt)
PT (1) PT1311486E (pt)
RU (2) RU2350326C2 (pt)
WO (1) WO2002016325A1 (pt)
ZA (1) ZA200209965B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843963B1 (fr) * 2002-08-30 2004-10-22 Sederma Sa Nouvelles molecules derivees de la noraporphine
AU2003242227A1 (en) * 2003-06-19 2005-01-04 Lotus Pharmaceutical Co., Ltd. Aporphine and oxoaporphine and the medical use thereof
SG190914A1 (en) * 2010-11-24 2013-07-31 Dong A St Co Ltd Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757335C3 (de) * 1977-12-22 1982-03-25 Gödecke AG, 1000 Berlin Verfahren zur O-Methylierung von Hydroxyaporphinen
DE3118521A1 (de) * 1981-05-09 1982-12-02 Gödecke AG, 1000 Berlin Dibenzo(de,g)chinolin-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkaeltungskrankheiten und allergien
JPS6416722A (en) * 1987-07-13 1989-01-20 Tsumura & Co Blood viscosity lowering agent

Also Published As

Publication number Publication date
IL153205A (en) 2007-06-17
AU2001248226B2 (en) 2004-07-08
EP1311486B1 (en) 2006-05-03
IL153205A0 (en) 2003-07-06
DK1311486T3 (da) 2006-09-04
KR100522008B1 (ko) 2005-10-18
ZA200209965B (en) 2004-03-09
CN1176909C (zh) 2004-11-24
JP2004506719A (ja) 2004-03-04
ES2260209T3 (es) 2006-11-01
DE60119336T2 (de) 2007-05-10
CN1429212A (zh) 2003-07-09
RU2002133099A (ru) 2004-05-10
RU2350326C2 (ru) 2009-03-27
CA2412170C (en) 2007-01-02
RU2005140373A (ru) 2007-06-27
EP1311486A4 (en) 2004-03-31
BR0111761A (pt) 2003-06-24
CY1105432T1 (el) 2010-04-28
EP1311486A1 (en) 2003-05-21
HUP0301971A3 (en) 2007-09-28
CA2412170A1 (en) 2002-02-28
HUP0301971A2 (hu) 2003-09-29
KR20030009533A (ko) 2003-01-29
WO2002016325A1 (en) 2002-02-28
MXPA02012316A (es) 2005-04-19
DE60119336D1 (de) 2006-06-08
ATE325099T1 (de) 2006-06-15
AU4822601A (en) 2002-03-04

Similar Documents

Publication Publication Date Title
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
NL980011I1 (nl) 7-Piperazinyl- of 7-morfolino-4-oxo-chinoline-3-carbonzuurderivaten, hun bereiding en hun gebruik als anti-microbiële middelen.
PT1068870E (pt) Agentes antitumorais
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
NO985643L (no) Antimikrobielle blandinger
EE04854B1 (et) Oksabispidiinühendid, nende valmistamise meetod ning ravimvorm kasutamiseks südame arütmia raviks ja profülaktikaks
PT1263504E (pt) Compostos com actividade 5-ht1a uteis para o tratamento de perturbacoes da retina externa
ES2192832T3 (es) Uso de compuestos macrolidos para tratar glaucoma.
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
BR9814299A (pt) Aminobiguanidas e o seu uso para desinfetarlentes de contato e preservar composiçõesfarmacêuticas
PT1089704E (pt) Locao tricologica para aplicacao topica
TR200101649T2 (tr) Piperazin türevleri.
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
EE200200305A (et) Südame arütmiate ravis kasutatavad uued asabitsüklooktaani derivaadid
ES2124983T3 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
EE200300364A (et) 3,7-diasabitsüklo[3,3,0]oktaanid ja nende kasutamine südame arütmiate ravis
ATE313541T1 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
PT1311486E (pt) Uso de taliporfina ou dos seus derivados no tratamento de doencas cardiacas e preparacao da mesma
EP1269978A3 (de) Verwendung von Bis-Resorcinyltriazinderivaten in kosmetischen oder dermatologischen Zubereitungen
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
EE200300506A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
NO20032006D0 (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
HUP0402241A2 (hu) Metformin és 4-oxo-butánsav kombinációját tartalmazó gyógyászati készítmény, és a készítmény alkalmazása diabétesz kezelésére
DE69813833D1 (de) 4-cyano-4-deformylsordarizin-derivate
ATE241640T1 (de) Fusidinsäure-derivate